Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fc gamma receptors (FcγRs) are a family of cell surface receptors that bind to the Fc region of immunoglobulin G (IgG) antibodies and play a central role in linking humoral and cellular immunity. The three main classes on antigen-presenting cells (APCs) are Fc gamma receptor I (FcγRI, CD64), Fc gamma receptor II (FcγRII, CD32), and Fc gamma receptor III (FcγRIII, CD16). They differ in their structure, affinity for IgG subclasses, and their intracellular signaling motifs, which can be activating (ITAM) or inhibitory (ITIM). These receptors mediate key immune functions such as phagocytosis, antigen presentation, ADCC, and regulation of cytokine secretion, and are implicated in both host defense and in the pathology of autoimmune and inflammatory diseases. Their genetic diversity and expression levels can affect susceptibility to disease and response to antibody therapies[1][2][5][7][9].
Triggering phagocytosis via ITAM-mediated signaling Inducing ADCC via NK cell activation Modulating cytokine production and degranulation Inhibiting immune activation (for FcγRIIB via ITIM motif) Altering antibody effector function through Fc engineering
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fc gamma receptor I (CD64), Fc gamma receptor II (CD32), Fc gamma receptor III (CD16) (FcγRI (CD64), FcγRII (CD32), FcγRIII (CD16)).